论文部分内容阅读
目的观察、评价复方阿胶浆预防化疗引起的患者血象下降的有效性。方法选取确诊的恶性肿瘤患者49例,随机分为试验组(24例)与对照组(25例)。2组均接受化疗,试验组在化疗基础上加用复方阿胶浆。记录2组化疗前、第7、14和21天时血象水平[红细胞(RBC)、白细胞(WBC)、中性粒细胞绝对计数(ANC)、血红蛋白(Hb)、血小板(PLT)],QLQ-C30评分、ECOG评分及不良反应,对复方阿胶浆预防化疗引起的患者血象下降的有效性进行分析。结果 2组第21天Hb水平下降幅度比较差异有统计学意义(P<0.05),试验组Hb改善总有效率明显高于对照组(P<0.05),其余指标比较差异均无统计学意义(P>0.05),化疗后第21天2组ECOG评分和QLQ-C30评分比较差异无统计学意义(P>0.05)。结论复方阿胶浆可有效改善化疗患者贫血现象,尚不能佐证其有升高白细胞和血小板作用,在提高患者生活质量方面作用亦不明显。
Objective To observe and evaluate the effectiveness of compound donkey-hide gelatin in preventing the decline of blood in patients caused by chemotherapy. Methods Forty-nine patients with confirmed malignant tumors were randomly divided into experimental group (24 cases) and control group (25 cases). Both groups received chemotherapy, and the experimental group added compound gelatin on the basis of chemotherapy. The blood levels (RBC, WBC, neutrophil count (ANC), hemoglobin (Hb), PLT), QLQ-C30 Score, ECOG score and adverse reactions, to analyze the efficacy of compound gelatin in the prevention of chemotherapy-induced decline in patients with blood. Results The decrease of Hb level on the 21st day in the two groups was statistically significant (P <0.05). The total effective rate of Hb improvement in the experimental group was significantly higher than that in the control group (P <0.05), and there was no significant difference in other indexes P> 0.05). There was no significant difference in ECOG score and QLQ-C30 score between the two groups on the 21st day after chemotherapy (P> 0.05). Conclusion Compound gelatin can effectively improve the anemia in patients with chemotherapy, yet can not support its role in raising white blood cells and platelets, in improving the quality of life of patients is not obvious.